Subscribe via RSS- NEWS ARCHIVES
-
2008
2007
2006
2005
2004
Pharma & Bio Ingredients
Dr. Tepper was one of the founding executives of Millennium in 1994 and has steered the company through its expansion from a drug discovery company to a fully-integrated biopharmaceutical company with nine novel molecules in the clinic and a market-leading product, Velcade (bortezomib) for Injection, for relapsed multiple myeloma and mantle cell lymphoma.
"Bob was one of a small group of people who had a vision for forming a new company that could make a difference in the way medicine is discovered to change the lives of patients," said Millennium president and chief executive officer Deborah Dunsire, M.D. "Today that vision is a reality and Millennium is indeed improving the lives of patients with multiple myeloma and mantle cell lymphoma, with a strong and diverse pipeline behind Velcade. I would like to thank Bob for his vision and relentless commitment to scientific excellence."
